Dyne Therapeutics Inc at Stifel Healthcare Conference Transcript
Great. I think we're ready to get started with this session here. Happy to be hosting the Dyne Therapeutics team, Oxana and Jonathan; Chief Scientific Officer and Head of Business Development, right?
Yes.
Great. Thanks for joining. So Dyne is a muscle focused company with two studies ongoing, both going to have some data next year. Either Jonathan or Oxana, do you wanted to just set the stage and give us an update on the DMD and DM1 programs and then we can do Q&A?
Yes, sure. So first, thanks for having us here today. It is really a great time to be able to share an update on Dyne. Very exciting time for the company. Before we get started, we will be making some forward-looking statements today, so please refer to our SEC filings for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
